This protocol covers the acute adjuvant management of trigeminal neuralgia in patients receiving systemic medications. A key clinical distinction drives the choice of intervention: whether or not a defined trigger point is identifiable.
Where a defined trigger point is present, localised interventional options are available to provide acute relief alongside systemic therapy. Where no trigger point can be identified, an alternative adjuvant approach is used instead.
For medium-term management, an additional agent may be considered in combination with ongoing systemic treatment, though the evidence base for this option is limited.